My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 1242

    1.

    Sustained virologic response and clinical outcomes in patients with chronic hepatitis C and advanced fibrosis.

    Veldt BJ, Heathcote EJ, Wedemeyer H, Reichen J, Hofmann WP, Zeuzem S, Manns MP, Hansen BE, Schalm SW, Janssen HL.

    Ann Intern Med. 2007 Nov 20;147(10):677-84.PMID: 18025443 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Summaries for patients. Sustained virologic response in hepatitis C.

    [No authors listed]

    Ann Intern Med. 2007 Nov 20;147(10):I47. No abstract available. PMID: 18025441 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Predictors of alpha-fetoprotein elevation in patients with chronic hepatitis C, but not hepatocellular carcinoma, and its normalization after pegylated interferon alfa 2a-ribavirin combination therapy.

    Chen TM, Huang PT, Tsai MH, Lin LF, Liu CC, Ho KS, Siauw CP, Chao PL, Tung JN.

    J Gastroenterol Hepatol. 2007 May;22(5):669-75.PMID: 17444854 [PubMed - indexed for MEDLINE]Related articles

    4.

    Antiviral therapy for cirrhotic hepatitis C: association with reduced hepatocellular carcinoma development and improved survival.

    Shiratori Y, Ito Y, Yokosuka O, Imazeki F, Nakata R, Tanaka N, Arakawa Y, Hashimoto E, Hirota K, Yoshida H, Ohashi Y, Omata M; Tokyo-Chiba Hepatitis Research Group.

    Ann Intern Med. 2005 Jan 18;142(2):105-14.PMID: 15657158 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Sustained virological response to interferon plus ribavirin reduces liver-related complications and mortality in patients coinfected with human immunodeficiency virus and hepatitis C virus.

    Berenguer J, Alvarez-Pellicer J, Martín PM, López-Aldeguer J, Von-Wichmann MA, Quereda C, Mallolas J, Sanz J, Tural C, Bellón JM, González-García J; GESIDA3603/5607 Study Group.

    Hepatology. 2009 Aug;50(2):407-13.PMID: 19575364 [PubMed - indexed for MEDLINE]Related articles

    6.

    Interleukin-2 plus ribavirin versus interferon-alpha-2b plus ribavirin in patients with chronic hepatitis C who did not respond to previous interferon-alpha-2b treatment.

    Malaguarnera M, Pistone G, Neri S, Romano M, Brogna A, Musumeci S.

    BioDrugs. 2004;18(6):407-13.PMID: 15571424 [PubMed - indexed for MEDLINE]Related articles

    7.

    Long-term histologic improvement and loss of detectable intrahepatic HCV RNA in patients with chronic hepatitis C and sustained response to interferon-alpha therapy.

    Marcellin P, Boyer N, Gervais A, Martinot M, Pouteau M, Castelnau C, Kilani A, Areias J, Auperin A, Benhamou JP, Degott C, Erlinger S.

    Ann Intern Med. 1997 Nov 15;127(10):875-81.PMID: 9382365 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Baseline serum low-density lipoprotein cholesterol levels predict response to hepatitis C virus therapy in HIV/hepatitis C virus coinfected patients.

    del Valle J, Mira JA, de los Santos I, López-Cortés LF, Merino D, Rivero A, Girón JA, Ríos-Villegas MJ, González-Serrano M, Collado A, García-García JA, Pineda JA.

    AIDS. 2008 May 11;22(8):923-30.PMID: 18453851 [PubMed - indexed for MEDLINE]Related articles

    9.

    Effect of interferon therapy on the incidence of hepatocellular carcinoma and mortality of patients with chronic hepatitis C: a retrospective cohort study of 738 patients.

    Tanaka H, Tsukuma H, Kasahara A, Hayashi N, Yoshihara H, Masuzawa M, Kanda T, Kashiwagi T, Inoue A, Kato M, Oshima A, Kinoshita Y, Kamada T.

    Int J Cancer. 2000 Sep 1;87(5):741-9.PMID: 10925370 [PubMed - indexed for MEDLINE]Related articles

    10.

    Sustained virologic response is associated with improved health-related quality of life in relapsed chronic hepatitis C patients.

    Neary MP, Cort S, Bayliss MS, Ware JE Jr.

    Semin Liver Dis. 1999;19 Suppl 1:77-85.PMID: 10349695 [PubMed - indexed for MEDLINE]Related articles

    11.

    Safety and efficacy of peginterferon plus ribavirin in patients with chronic hepatitis C and bridging fibrosis or cirrhosis.

    Marrache F, Consigny Y, Ripault MP, Cazals-Hatem D, Martinot M, Boyer N, Degott C, Valla D, Marcellin P.

    J Viral Hepat. 2005 Jul;12(4):421-8.PMID: 15985014 [PubMed - indexed for MEDLINE]Related articles

    12.

    Improved response to ribavirin interferon combination compared with interferon alone in patients with type 4 chronic hepatitis C without cirrhosis.

    Koshy A, Marcellin P, Martinot M, Madda JP.

    Liver. 2000 Jul;20(4):335-9.PMID: 10959813 [PubMed - indexed for MEDLINE]Related articles

    13.

    Relation of interferon therapy and hepatocellular carcinoma in patients with chronic hepatitis C. Osaka Hepatocellular Carcinoma Prevention Study Group.

    Imai Y, Kawata S, Tamura S, Yabuuchi I, Noda S, Inada M, Maeda Y, Shirai Y, Fukuzaki T, Kaji I, Ishikawa H, Matsuda Y, Nishikawa M, Seki K, Matsuzawa Y.

    Ann Intern Med. 1998 Jul 15;129(2):94-9.PMID: 9669992 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Prolonged therapy of advanced chronic hepatitis C with low-dose peginterferon.

    Di Bisceglie AM, Shiffman ML, Everson GT, Lindsay KL, Everhart JE, Wright EC, Lee WM, Lok AS, Bonkovsky HL, Morgan TR, Ghany MG, Morishima C, Snow KK, Dienstag JL; HALT-C Trial Investigators.

    N Engl J Med. 2008 Dec 4;359(23):2429-41.PMID: 19052125 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Histologic improvement of fibrosis in patients with hepatitis C who have sustained response to interferon therapy.

    Shiratori Y, Imazeki F, Moriyama M, Yano M, Arakawa Y, Yokosuka O, Kuroki T, Nishiguchi S, Sata M, Yamada G, Fujiyama S, Yoshida H, Omata M.

    Ann Intern Med. 2000 Apr 4;132(7):517-24.PMID: 10744587 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Pretreatment laparoscopic appearance of the liver can predict response to combination therapy with interferon alpha 2B and ribavirin in chronic hepatitis C.

    Bajaj JS, Molina E, Regev A, Schiff ER, Jeffers LJ.

    Gastrointest Endosc. 2003 Sep;58(3):380-3.PMID: 14528212 [PubMed - indexed for MEDLINE]Related articles

    17.

    Interferon-alpha and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis.

    Cacoub P, Lidove O, Maisonobe T, Duhaut P, Thibault V, Ghillani P, Myers RP, Leger JM, Servan J, Piette JC.

    Arthritis Rheum. 2002 Dec;46(12):3317-26.PMID: 12483738 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Clinical, virologic, histologic, and biochemical outcomes after successful HCV therapy: a 5-year follow-up of 150 patients.

    George SL, Bacon BR, Brunt EM, Mihindukulasuriya KL, Hoffmann J, Di Bisceglie AM.

    Hepatology. 2009 Mar;49(3):729-38.PMID: 19072828 [PubMed - indexed for MEDLINE]Related articles

    19.

    Pegylated interferon alpha-2b plus ribavirin for naive patients with HCV-related cirrhosis.

    Floreani A, Baldo V, Rizzotto ER, Carderi I, Baldovin T, Minola E.

    J Clin Gastroenterol. 2008 Jul;42(6):734-7.PMID: 18285717 [PubMed - indexed for MEDLINE]Related articles

    20.

    Treatment of hepatitis C virus-related cirrhosis: a randomized, controlled trial of interferon alfa-2b versus no treatment.

    Valla DC, Chevallier M, Marcellin P, Payen JL, Trepo C, Fonck M, Bourliere M, Boucher E, Miguet JP, Parlier D, Lemonnier C, Opolon P.

    Hepatology. 1999 Jun;29(6):1870-5.PMID: 10347132 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity